Login / Signup

Effect of Heart Failure Pharmacotherapies in Patients with Heart Failure with Mildly Reduced Ejection Fraction.

Tobias SchuppThomas BertschMarielen ReinhardtNoah AbelAlexander SchmittFelix LauMohammad AbumayyalehMuharrem AkinChristel WeißKathrin WeidnerMichael BehnesIbrahim Akin
Published in: European journal of preventive cardiology (2024)
BB, ACEi/ARB/ARNI and SGLT2i were independently associated with lower risk of all-cause mortality in patients with HFmrEF, specifically when applied as combined "HF triple therapy". Randomized studies are needed to investigate the effect of HF-related pharmacotherapies in patients with HFmrEF.
Keyphrases